IMPACT OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE ON ADULTS WITH ASTHMA EXACERBATION

Authors

  • SUTARYONO Doctoral Program in Environmental Science, Universitas Sebelas Maret, Indonesia.
  • HARTONO Department of Physiology, Faculty of Medicine, Universitas Sebelas Maret, Indonesia.
  • ARI PROBANDARI Department of Public Health, Faculty of Medicine, Universitas Sebelas Maret, Indonesia.
  • PRABANG SETYONO Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret, Indonesia

DOI:

https://doi.org/10.22159/ajpcr.2019.v12i3.28498

Keywords:

Environmental tobacco smoke, Cotinine, Survival, Asthma, Exacerbation

Abstract

Objective: Environment tobacco smoke (ETS) exposure in the household is dangerous to infants and children. Nicotine residue inhaled in the respiratory tract metabolized into cotinine which has the possibility of causing inflammation which can result in asthma exacerbation. The impact created by the exposure of ETS on children suffering from asthma is the sole objective of this research work.

Methods: A cohort study was carried out among 114 asthma patients aged 12–18 years old at three hospitals from January 2016 to March 2017. Data were obtained using self-reported questionnaires and cotinine urine test. The data analysis was carried with the use of Cox proportional hazard model with 95% confidence interval (CI).

Results: The result of the research showed that 57% of the patients got the trigger (event). The respondents consisted of 61.5% of female, average age of 15 years, 50.8% of upper secondary education, 55.4% of body mass index (BMI) normal, and 63.1% low economic status persons. Median survival for the ETS-exposed group was in a 9th week, while the median survival for the ETS non-exposed group was >12 weeks. Multivariate exposure of ETS with asthma exacerbation was hazard ratio (HR), 2.17; 95% CI, 1.23–3.83, p=0.008 and gender HR, 1.72; 95% CI, 1.04–2.85, p=0.035.

Conclusion: ETS exposure in the household increases the risk of asthma exacerbation. Controlling the environment and education of children to avoid ETS exposure should be intensified.

Downloads

Download data is not yet available.

Author Biography

SUTARYONO, Doctoral Program in Environmental Science, Universitas Sebelas Maret, Indonesia.

Department of Pharmacy

References

World Health Organization. Global Status Report on Noncommunicable Diseases; 2010. Available from: http://www.who.int/about/licensing/copyright_form/en/index.html. [Last accessed on 2016 Aug 29].

World Health Organization. Facts on Secondhand Smoke; 2017. Available from: http://www.who.int/news-room/fact-sheets/detail/tobacco. [Last accessed on 2018 May 21].

Treyster Z, Gitterman B. Second hand smoke exposure in children: Environmental factors, physiological effects, and interventions within pediatrics. Rev Environ Health 2011;26:187-95.

Jyothirmayi B, Kaviarasi S, William E. Study of glycated hemoglobin in chronic cigarette smokers. Int J Pharm Clin Res 2013;5:4-6.

Hireche A, Chaoui-kherouatou N, Ribouh A, Abadi N, Shi M, Satta D. Polymorphic deletions of glutathione s-transferases m1, t1 and bladder cancer risk in Algerian population. Asian J Pharm Clin Res 2018;11:458.

Center for Disease Control and Prevention. Fact Sheet 2010 Surgeon General’s Report How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. Available from: https://www.cdc.gov/tobacco/data_statistics/sgr/2010/index.htm. [Last accessed on 2017 May 31].

Doss DS, Anandhalakshmi S, Rekha K, Antony KA. Effect of smoking on heart rate variability in normal healthy volunteers. Asian J Pharm Clin Res 2016;9:230-4.

Shivasekar M, Vinodhini VM, Kumar YR. Study of serum ferritin in smokers. Asian J Pharm Clin Res 2018;11:11-12.

Sajid N, Bangash AL, Hashim N, Ismail NE. Smoking status affecting survival of adenocarcinoma lung cancer patients in Kuala Lumpur, Malaysia. Asian J Pharm Clin Res 2017;10:63-4.

Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. Glob Initiat Asthma; 2016. p. 28.

Riset Kesehatan Dasar. Badan Penelitian dan Pengembangan Kesehatan. Balitbangkes. Riset Kesehatan Dasar; 2013.

Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010;126:187-97.

Rina A, Eff Y. Incidence of hypertension in asthma patients who treated with beta-2 agonists bronchodilators. Int J Pharm Pharm Sci 2017;9:2-5.

Willers S, Gerhardsson L, Lundh T. Environmental tobacco smoke (ETS) exposure in children with asthma-relation between lead and cadmium, and cotinine concentrations in urine. Respir Med 2005;99:1521-7.

Hoh E, Hunt RN, Quintana PJ, Zakarian JM, Chatfield DA, Wittry BC, et al. Environmental tobacco smoke as a source of polycyclic aromatic hydrocarbons in settled household dust. Environ Sci Technol 2012;46:4174-83.

Perfetti T. The chemical components of tobacco and tobacco smoke. Chromatographia 2010;71:977.

Montefort S, Ellul P, Montefort M, Caruana S, Grech V, Agius Muscat H, et al. The effect of cigarette smoking on allergic conditions in maltese children (ISAAC). Pediatr Allergy Immunol 2012;23:472-8.

Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987;42:241-9.

Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998;83:148-56.

Koenig JQ, Mar TF, Allen RW, Jansen K, Lumley T, Sullivan JH, et al. Pulmonary effects of indoor- and outdoor-generated particles in children with asthma. Environ Health Perspect 2005;113:499-503.

Gullstén H. Significance of Polymorphisms in CYP2A6 Gene. Oulu: Department of Pharmacology and Toxicology, University of Oulu; 2000.

Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, et al. Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 2000;58:747-55.

Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.

Davies GE, Soundy TJ. The genetics of smoking and nicotine addiction. S D Med 2009;Spec No:43-9.

Mao J, Liu J, Pang X, Li M, Song J, Han C, et al. Nicotine induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophages. Mol Cells 2012;34:457-61.

Nagasaki T, Matsumoto H, Nakaji H, Niimi A, Ito I, Oguma T, et al. Smoking attenuates the age-related decrease in igE levels and maintains eosinophilic inflammation. Clin Exp Allergy 2013;43:608-15.

Mshimesh BA. Effects of etoricoxib, zileuton, and their combination on urinary PGE-M and LTE4 levels in iraqi smokers: A comparative study. Int J Pharm Pharm Sci 2016;8:182-7.

Seccareccia F, Zuccaro P, Pacifici R, Meli P, Pannozzo F, Freeman KM, et al. Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: The experience of the MATISS project. Eur J Epidemiol 2003;18:487-92.

Matsumoto A, Ino T, Ohta M, Otani T, Hanada S, Sakuraoka A, et al. Enzyme-linked immunosorbent assay of nicotine metabolites. Environ Health Prev Med 2010;15:211-6.

Kalkbrenner AE, Hornung RW, Bernert JT, Hammond SK, Braun JM, Lanphear BP, et al. Determinants of serum cotinine and hair cotinine as biomarkers of childhood secondhand smoke exposure. J Expo Sci Environ Epidemiol 2010;20:615-24.

Avila-Tang E, Al-Delaimy WK, Ashley DL, Bernert JT, Kim S, Samet JM. Assessing secondhand smoke using biological markers. Tob Control 2013;22:164-71.

Karadag B, Karakoc F, Ceran O, Ersu R, Inan S, Dagli E. Does passive smoke exposure trigger acute asthma attack in children? Allergol Immunopathol (Madr) 2003;31:318-23.

Jingyi Xu, Smiley-Jewell S, Claude J, Pinkerton KE. Effects of environmental tobacco smoke during early life stages. Lung 2015 ;12:385-97.

Sutaryono P, Hartono H, Probandari NA, Setyono P, Budiastuti S, Masykuri M. Association between Exposure to Environmental Tobacco Smoke and the Risk of Uncontrolled Asthma in Children. In: International Conference on Public Health. Indonesia: Masters Program in Public Health, Graduate School, Universitas Sebelas Maret.

Chilmonczyk BA, Luis M, Salmun R, Keith N, Megathlin L, Louis M, et al. Association between exposure to environmental tobacco smoke and exacerbation of asthma in children. N Engl J Med 1993;328:1665-9.

Gergen PJ, Fowler JA, Maurer KR, Davis WW, Overpeck MD. The burden of environmental tobacco smoke exposure on the respiratory health of children 2 months through 5 years of age in the United States: Third national health and nutrition examination survey, 1988 to 1994. Pediatrics 1998;101:E8.

Gilliland FD, Islam T, Berhane K, Gauderman WJ, McConnell R, Avol E, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med 2006;174:1094-100.

Yang GH, Ma JM, Liu N, Zhou LN. Smoking and passive smoking in chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:77-83.

Hayatbakhsh MR, Sadasivam S, Mamun AA, Najman JM, Williams GM, O’Callaghan MJ, et al. Maternal smoking during and after pregnancy and lung function in early adulthood: A prospective study. Thorax 2009;64:810-4.

Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107 Suppl 2:349-55.

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG Vina L. GEMA (Spanish guideline on the management of asthma). Arch Bronconeumol 2009;45 Supl 7:2-35.

Jindal SK, Gupta D. The relationship between tobacco smoke and amp; bronchial asthma. Indian J Med Res 2004;120:443-53.

Di Stefano A, Capelli A, Lusuardi M, Caramori G, Balbo P, Ioli F, et al. Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy 2001;31:893-902.

Prakruthi GM, Bharathi DR, Yogananda R. A case control study on determinants of childhood asthma in school children of Chitradurga city. Int J Curr Pharm Res 2018;10:11-5.

Mahmudah RA, Adnyana IK, Kurnia N. Anti-asthma activity of tamarind pulp extract (Tamarindus indica L.). Int J Curr Pharm Res 2017;9:3-6.

Published

07-03-2019

How to Cite

SUTARYONO, HARTONO, A. PROBANDARI, and P. SETYONO. “IMPACT OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE ON ADULTS WITH ASTHMA EXACERBATION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 12, no. 3, Mar. 2019, pp. 125-9, doi:10.22159/ajpcr.2019.v12i3.28498.

Issue

Section

Original Article(s)